BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 20004512)

  • 1. MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications.
    Rachagani S; Kumar S; Batra SK
    Cancer Lett; 2010 Jun; 292(1):8-16. PubMed ID: 20004512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
    Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK
    Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis, treatment and prognosis evaluation of pancreatic cancer by microRNA].
    Ren H; Wang CF
    Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):903-906. PubMed ID: 33256299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential.
    Rawat M; Kadian K; Gupta Y; Kumar A; Chain PSG; Kovbasnjuk O; Kumar S; Parasher G
    Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31557962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting microRNAs in pancreatic cancer: microplayers in the big game.
    Khan S; Ansarullah ; Kumar D; Jaggi M; Chauhan SC
    Cancer Res; 2013 Nov; 73(22):6541-7. PubMed ID: 24204026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in pancreatic ductal adenocarcinoma: new diagnostic and therapeutic clues.
    Seux M; Iovanna J; Dagorn JC; Dusetti NJ
    Pancreatology; 2009; 9(1-2):66-72. PubMed ID: 19077456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA expression and its clinical implications for the prevention and diagnosis of non-small-cell lung cancer.
    Gao W; Xu J; Shu YQ
    Expert Rev Respir Med; 2011 Oct; 5(5):699-709. PubMed ID: 21955239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring miRNA based approaches in cancer diagnostics and therapeutics.
    Mishra S; Yadav T; Rani V
    Crit Rev Oncol Hematol; 2016 Feb; 98():12-23. PubMed ID: 26481951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis.
    Zhang Y; Li M; Wang H; Fisher WE; Lin PH; Yao Q; Chen C
    World J Surg; 2009 Apr; 33(4):698-709. PubMed ID: 19030927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs and cancer; an overview.
    Tutar L; Tutar E; Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):430-7. PubMed ID: 24846068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.
    Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S
    Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators.
    Daoud AZ; Mulholland EJ; Cole G; McCarthy HO
    BMC Cancer; 2019 Nov; 19(1):1130. PubMed ID: 31752758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MetastamiRs: non-coding MicroRNAs driving cancer invasion and metastasis.
    Lopez-Camarillo C; Marchat LA; Arechaga-Ocampo E; Perez-Plasencia C; Moral-Hernandez OD; Castaneda-Ortiz EJ; Rodriguez-Cuevas S
    Int J Mol Sci; 2012; 13(2):1347-1379. PubMed ID: 22408395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
    Brunetti O; Russo A; Scarpa A; Santini D; Reni M; Bittoni A; Azzariti A; Aprile G; Delcuratolo S; Signorile M; Gnoni A; Palermo L; Lorusso V; Cascinu S; Silvestris N
    Oncotarget; 2015 Sep; 6(27):23323-41. PubMed ID: 26259238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNAs and cancer: role in tumorigenesis, patient classification and therapy.
    Hernando E
    Clin Transl Oncol; 2007 Mar; 9(3):155-60. PubMed ID: 17403626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs as biomarkers and prospective therapeutic targets in colon and pancreatic cancers.
    Nagaraju GP; Madanraj AS; Aliya S; Rajitha B; Alese OB; Kariali E; Alam A; El-Rayes BF
    Tumour Biol; 2016 Jan; 37(1):97-104. PubMed ID: 26537581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs as biomarkers and perspectives in the therapy of pancreatic cancer.
    Xia T; Chen XY; Zhang YN
    Mol Cell Biochem; 2021 Dec; 476(12):4191-4203. PubMed ID: 34324119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer.
    Abulsoud AI; Elshaer SS; Abdelmaksoud NM; Zaki MB; El-Mahdy HA; Ismail A; Al-Noshokaty TM; Fathi D; Abdel-Reheim MA; Mohammed OA; Doghish AS
    Pathol Res Pract; 2023 Nov; 251():154855. PubMed ID: 37806169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profile of MicroRNA: An Emerging Hallmark of Cancer.
    Zaheer U; Faheem M; Qadri I; Begum N; Yassine HM; Al Thani AA; Mathew S
    Curr Pharm Des; 2019; 25(6):642-653. PubMed ID: 30914015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis.
    Song B; Ju J
    Expert Rev Mol Med; 2010 Oct; 12():e33. PubMed ID: 20942990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.